Health Catalyst Inc. (HCAT) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Health Catalyst Inc. (HCAT:NASDAQ), powered by AI.

Current Price
$1.94
P/E Ratio
-0.8
Market Cap
136M
Sector
Healthcare
What is the Health Catalyst Inc. stock price forecast?

Health Catalyst Inc. is currently trading at $1.94. View real-time AI analysis on Alpha Lenz.

What is Health Catalyst Inc. insider trading activity?

View the latest insider trading data for Health Catalyst Inc. on Alpha Lenz.

What is Health Catalyst Inc.'s P/E ratio?

Health Catalyst Inc.'s P/E ratio is -0.8.

Health Catalyst Inc.

NASDAQ · HCAT
$1.94+0.61(+45.86%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Health Catalyst Inc.'s future dividend policy...
Alpha Chat Insight

Health Catalyst Inc. trades at a P/E of -0.8 (undervalued) with modest ROE of -58.3%.

Ask for details

Company Overview

Health Catalyst Inc. is a technology company that provides data and analytics solutions to healthcare organizations. Its primary function is to help healthcare providers improve clinical and financial outcomes by leveraging data-driven insights. The company offers a comprehensive software platform known as Data Operating System (DOS), which aggregates and analyzes vast amounts of healthcare data. This platform supports a range of applications, including quality improvement, patient safety, and operational efficiency. Health Catalyst Inc. serves various sectors within the healthcare industry, including hospitals, physician practices, and health systems. The solutions provided by Health Catalyst aim to enhance decision-making processes by providing actionable insights that help reduce costs, improve patient care, and streamline operations. In the financial market, Health Catalyst Inc. is recognized for its vital role in the digital transformation of healthcare, marked by its innovative approach to utilizing big data. As healthcare systems increasingly adopt technological solutions to optimize their practices, Health Catalyst stands as a significant player, enabling institutions to harness the power of data to achieve better outcomes.

CEOMr. Daniel D. Burton
SectorHealthcare
IndustryHealth Information Services
Employees1,500

Company Statistics

FY 2025

Profile

$135.60MMarket Cap
$311.14MRevenue
0.00Shares Out
1,500Employees

Margins

48.75%Gross
5.02%EBITDA
-13.74%Operating
-56.97%Pre-Tax
-57.20%Net

Valuation

-0.76P/E
0.55P/B
0.44EV/Sales
16.41EV/EBITDA
-6.51P/FCF

Growth (CAGR)

4.05%Rev 3Yr
10.50%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-26.14%ROA
-58.26%ROE
-22.47%ROIC

Financial Health

$50.81MCash & Cash Equivalents
$206.05MNet Debt
104.51%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Health Catalyst Inc. (ticker: HCAT) is a company listed on NASDAQ in the Healthcare sector (Health Information Services). It has approximately 1,500 employees. Market cap is $136M.

The current price is $1.94 with a P/E ratio of -0.76x and P/B of 0.55x.

ROE is -58.26% and operating margin is -13.74%. Annual revenue is $311M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Health Catalyst Inc. (HCAT) Stock Forecast 2026 $1.94 — Price, Financials & Analyst Targets | Alpha Lenz